Racial differences in PSA screening interval and stage at diagnosis
- 24 March 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Causes & Control
- Vol. 21 (7), 1071-1080
- https://doi.org/10.1007/s10552-010-9535-4
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Racial differences in trust and regular source of patient care and the implications for prostate cancer screening useCancer, 2009
- Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology GroupJNCI Journal of the National Cancer Institute, 2009
- Screening for Prostate Cancer — The Controversy That Refuses to DieNew England Journal of Medicine, 2009
- Mortality Results from a Randomized Prostate-Cancer Screening TrialNew England Journal of Medicine, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- A Matter Of Race: Early-Versus Late-Stage Cancer DiagnosisHealth Affairs, 2009
- Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control studyBMC Medicine, 2008
- Reduction of Prostate Cancer Mortality in Tyrol, Austria, after Introduction of Prostate-specific Antigen TestingAmerican Journal of Epidemiology, 2006
- Racial Differences in the Treatment of Early-Stage Lung CancerNew England Journal of Medicine, 1999
- TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMESThe Lancet, 1987